Science exists
to lift the brain fog
Struggling to think clearly after Long COVID, chemotherapy or menopause? You're not alone — and there are evidence-informed solutions.
AI Digital Guided Brain Training
Personalised cognitive exercise programme on a neuroplasticity-based, AI-guided digital platform. Strengthens attention, memory and executive functions.
Epigenetic Coaching
A personalised coaching programme that examines how lifestyle factors (nutrition, sleep, stress, movement, and environment) influence gene expression, and translates that insight into practical, evidence-informed daily habits to support cognitive and overall wellbeing.
Adult focus & organisation coaching
Discover your own attention profile using the MOXO test. Not every neurodivergent experience needs a diagnosis or label — we help you understand your strengths and manage daily life better.
Know Yourself — Adult Dyslexia Profile
Make sense of your reading and writing difficulties. A diagnosis is not required — discover your own learning profile and learn to use your strengths at work, in daily life and beyond.
Menopause Cognitive Support
SAS-Clarity™ auditory neurostimulation with separately calibrated programmes for pre-, peri- and post-menopause.
Long COVID Brain Fog Programme
SAS-Clarity™ frequency protocol calibrated for post-exertional malaise risk. Supports cognitive capacity without draining your energy.
Post-Chemotherapy Cognitive Support (CRCI)
Specialised SAS-Clarity™ profile targeting neurotoxic effects of chemotherapy.
What is SAS-Clarity™
and how does it work?
Auditory neurostimulation is an evidence-informed, non-pharmacological approach that uses the brain's own frequencies.
SAS-Clarity™ was designed by Coşkunçay based on 31 peer-reviewed sources including MIT, Nature Communications and the Lancet.
Menopause — 3 separate modules
Separately calibrated programmes for pre-, peri- and post-menopause.
Long COVID Brain Fog
Low-intensity frequency protocol calibrated for post-exertional malaise risk.
Post-Chemotherapy (CRCI)
Specialised protocol targeting neurotoxic effects of chemotherapy.